Information  X 
Enter a valid email address

Ergomed PLC Ord 1P (ERGO)

Date Time Source Announcement
16 Jul 2018 5:31 pm
RNS
Change of auditor
04 Jul 2018 11:11 am
RNS
Issue of shares
03 Jul 2018 7:00 am
RNS
Award of share options
02 Jul 2018 7:00 am
RNS
Board appointment
28 Jun 2018 7:00 am
RNS
Trading Update
27 Jun 2018 11:52 am
RNS
Block listing application
21 Jun 2018 9:11 am
RNS
Exercise of options
15 Jun 2018 3:14 pm
RNS
Change of Registered Office
12 Jun 2018 3:55 pm
RNS
Results of 2018 Annual General Meeting
25 May 2018 7:00 am
RNS
Key hire in pharmacoepidemiology services
24 May 2018 4:00 pm
RNS
Holding(s) in Company
21 May 2018 3:35 pm
RNS
Notice of AGM
02 May 2018 7:00 am
RNS
Holdings in Company
26 Apr 2018 9:58 am
RNS
Issue of shares and PDMR
17 Apr 2018 5:47 pm
RNS
Holdings in Company
  5:47 pm
RNS
Holdings in Company
16 Apr 2018 3:55 pm
RNS
Directors' Dealing
11 Apr 2018 7:00 am
RNS
Preliminary Results
09 Apr 2018 6:26 pm
RNS
Holding(s) in Company
20 Mar 2018 7:00 am
RNS
Notice of Preliminary Results: Date Change
05 Mar 2018 7:00 am
RNS
Trading Update & Notice of Results
21 Feb 2018 2:35 pm
RNS
Holdings in Company
  2:35 pm
RNS
Holdings in Company
06 Feb 2018 2:03 pm
RNS
Holdings in Company
05 Feb 2018 5:07 pm
RNS
Holdings in Company
01 Feb 2018 9:39 am
RNS
Directors' Dealing
  7:00 am
RNS
Completion of Placing
25 Jan 2018 7:00 am
RNS
Ergomed 2017 Trading Update
10 Jan 2018 1:00 pm
RNS
Holdings in Company
15 Dec 2017 7:00 am
RNS
Board changes
12 Dec 2017 7:00 am
RNS
Co-dev partnership with Allergy Therapeutics
04 Dec 2017 7:00 am
RNS
Ergomed's PrimeVigilance hosts automation seminar
27 Nov 2017 7:00 am
RNS
Ergomed to present at the German Equity Forum 2017
23 Oct 2017 7:00 am
RNS
Ergomed's PeproStat reports positive results
12 Oct 2017 4:48 pm
RNS
Holding(s) in Company
03 Oct 2017 7:00 am
RNS
Completion of Acquisition of PSR Group BV
28 Sep 2017 10:46 am
RNS
Result of Placing
  7:02 am
RNS
Acquisition of PSR Group BV and Placing
27 Sep 2017 7:00 am
RNS
Commercialisation Deal on Haemostatix Products
18 Sep 2017 7:00 am
RNS
Interim Results
21 Aug 2017 7:06 am
RNS
CEL-SCI Corporation issues restricted shares
14 Aug 2017 12:31 pm
RNS
FDA removal of hold on Ph3 trial with Multikine
  7:00 am
RNS
Notice of Results
24 Jul 2017 7:00 am
RNS
Recruitment complete early for Phase IIb study
04 Jul 2017 12:30 pm
RNS
Investor Meeting
21 Jun 2017 7:00 am
RNS
PeproStat study passes recruitment mid-point
16 Jun 2017 5:44 pm
RNS
Result of AGM
  7:00 am
RNS
Appointment of CEO
22 May 2017 7:00 am
RNS
Appointment of N+1 Singer as joint broker
12 May 2017 4:54 pm
RNS
Annual Report and Notice of AGM
08 May 2017 12:00 pm
RNS
Issue of Shares to Former PharmInvent Shareholders
02 May 2017 7:00 am
RNS
Co-Development Partner News
13 Apr 2017 7:00 am
RNS
Board and Management Changes
04 Apr 2017 10:50 am
RNS
Director/PDMR Shareholding
03 Apr 2017 7:00 am
RNS
Partner Asarina Pharma announces successful data
28 Mar 2017 7:00 am
RNS
Unaudited Preliminary Results for 2016
21 Mar 2017 7:00 am
RNS
Notice of Preliminary Results
20 Mar 2017 7:00 am
RNS
Initiates Phase II Study of Topical PeproStat
20 Feb 2017 7:00 am
RNS
Modus Therapeutics Raises SEK 32 Million
06 Feb 2017 7:02 am
RNS
Positive Phase II top-line results of Lorediplon
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t